These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 19785511

  • 1. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
    Balu S, Simko RJ, Quimbo RM, Cziraky MJ.
    Curr Med Res Opin; 2009 Nov; 25(11):2765-75. PubMed ID: 19785511
    [Abstract] [Full Text] [Related]

  • 2. Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy.
    Charland SL, Malone DC.
    Curr Med Res Opin; 2010 Feb; 26(2):365-75. PubMed ID: 19995326
    [Abstract] [Full Text] [Related]

  • 3. Impact of antidepressant drug adherence on comorbid medication use and resource utilization.
    Katon W, Cantrell CR, Sokol MC, Chiao E, Gdovin JM.
    Arch Intern Med; 2005 Nov 28; 165(21):2497-503. PubMed ID: 16314547
    [Abstract] [Full Text] [Related]

  • 4. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV, Remigio-Baker RA, Thiebaud P, Preblick R, Plauschinat C.
    BMC Fam Pract; 2008 Nov 06; 9():61. PubMed ID: 18990240
    [Abstract] [Full Text] [Related]

  • 5. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
    Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL.
    Clin Ther; 2006 Oct 06; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
    [Abstract] [Full Text] [Related]

  • 6. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA, Chapman RH, Benner JS, Tang SS, Solomon HA, Joyce A, Foody JM.
    Am J Cardiovasc Drugs; 2010 Oct 06; 10(3):193-202. PubMed ID: 20387911
    [Abstract] [Full Text] [Related]

  • 7. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X, Gross CR, Schommer J, Cline R, St Peter WL.
    Clin Ther; 2007 Dec 06; 29(12):2748-57. PubMed ID: 18201593
    [Abstract] [Full Text] [Related]

  • 8. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.
    Clin Ther; 2007 Jun 06; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [Abstract] [Full Text] [Related]

  • 9. Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin.
    LaFleur J, Thompson CJ, Joish VN, Charland SL, Oderda GM, Brixner DI.
    Ann Pharmacother; 2006 Jun 06; 40(7-8):1274-9. PubMed ID: 16849622
    [Abstract] [Full Text] [Related]

  • 10. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
    Cheong C, Barner JC, Lawson KA, Johnsrud MT.
    Clin Ther; 2008 Oct 06; 30(10):1893-907. PubMed ID: 19014846
    [Abstract] [Full Text] [Related]

  • 11. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
    Jackson KC, Sheng X, Nelson RE, Keskinaslan A, Brixner DI.
    Clin Ther; 2008 Aug 06; 30(8):1558-63. PubMed ID: 18803997
    [Abstract] [Full Text] [Related]

  • 12. Predictors of adherence among Alzheimer's disease patients receiving oral therapy.
    Borah B, Sacco P, Zarotsky V.
    Curr Med Res Opin; 2010 Aug 06; 26(8):1957-65. PubMed ID: 20569067
    [Abstract] [Full Text] [Related]

  • 13. Does synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy?
    Agarwal S, Tang SS, Rosenberg N, Pettitt D, McLaughlin T, Joyce A, Schwartz JS.
    Am J Ther; 2009 Aug 06; 16(2):119-26. PubMed ID: 19114872
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
    Ballantyne CM, Davidson MH, McKenney J, Keller LH, Bajorunas DR, Karas RH.
    Am J Cardiol; 2008 May 15; 101(10):1428-36. PubMed ID: 18471454
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 May 15; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 19. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.
    Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S.
    Med Care; 2010 May 15; 48(5):418-25. PubMed ID: 20393367
    [Abstract] [Full Text] [Related]

  • 20. Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry.
    Ademi Z, Liew D, Hollingsworth B, Steg PG, Bhatt DL, Reid CM, REACH Registry Investigators.
    Am J Cardiovasc Drugs; 2010 May 15; 10(2):85-94. PubMed ID: 20334445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.